Juvenile Adamantiades-Behcet's disease with diminished response to stimulation with anti-CD3 monoclonal antibody;Juveniler Morbus Adamantiades-Behcet bei erniedrigter Stimulation mit Anti-CD3-monoklonalen Antikorper

Hautarzt

Volumn 48, Issue 4, 1997, Pages 258-261

  Krüger, Katja ^a,d   Fritz, Klaus ^a   Daniel, Volker ^b   Zouboulis, Christos C ^c  

^a Gemeinschaftspraxis Dr Klaus F   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Praxis Dr Guldner Engelmann Dr S   (Germany)

Author keywords

Adamantiades Bechet's disease; immune deficiency

Indexed keywords

INTERLEUKIN RECEPTOR; MONOCLONAL ANTIBODY CD3; CD3 ANTIGEN; HLA ANTIGEN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; HISTOLOGY; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE TRANSFORMATION TEST; MALE; MOUTH ULCER; SCHOOL CHILD; ASTHMA; BLOOD; CHILD; GENETICS; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NEUTROPHIL; PATHOLOGY; PHENOTYPE; SKIN;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ASTHMA; BEHCET SYNDROME; CHILD; HLA ANTIGENS; HUMANS; IGG DEFICIENCY; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; NEUTROPHILS; PHENOTYPE; SKIN;

EID: 0030974619     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050580     Document Type: Article

References (30)

1. Adamantiades B (1931) Sur un cas d'iritis àhypopyon récidivant. Ann Oculist (Pais) 168:271-278
2. Aydintug AO,Tokgoz G, D'Cruz DP, Gurler A, Cervera R, Düzgun N, Atmaca LS, Khamashta MA, Hughes GRV (1993) Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol 67:157-162
3. Balcan E, Ozgun S, Akoglu T, Yazici H (1993) Antibodies to keratin components in patients with Behçet's disease as compared by other rheumatological disorders. In:Wechsler B, Godeau P (eds) Behçet disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo, pp 87-90
4. Bang D, Honma T, Saito T, Nakagawa S, Ueki H, Lee S (1988) Ultrastructure of vascular changes in cutaneous manifestations of Behçet's disease. Acta Dermatol Venereol (Stockh) 68:33-40
5. Behçet H (1937)Über rezidivierende,aphthöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152-1157
6. Chajek-Shaul T, Pisanty S, Knobler H, Matzner Y, Click M, Ron N, Rosenman E, Brautbar C (1987) HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome. Am J Med 83:666-672
7. Cooke BED (1979) Oral ulceration in Behçet's syndrome. ln: Lehner T, Barnes CG (eds) Behçet's syndrome. Clinical and Immunological features. Proceeding of a conference sponsored by the Royal Society of Medicine, February 1979. Academic Press, London, pp 143-149
8. Dinehart S, Jorizoo JL (1988) Immunology: cellmediated immune system. In:Plotkin GR, Calabro JJ, O'Duffy JD (eds) Behçet's disease a contemporay synopsis. Future, Mount Kisco New York, pp 63-72
9. Djawari D (1934) Morbus Behçet. Klinische und immunopathologische Aspekte. Zentralbl Haut 150:83-94
10. Fortune F, Walker J, Lehner T (1990) The expression of γδ T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behçet's syndrome. Clin Exp Immunol 82:326-332
11. Gupta Rc, O'Duffy JD, McDuffie FC, Meurer M, Jordon RE (1978) Circulating immune complexes in active Behçet's disease. Clin Exp Immunol 34:213-218
12. Häfner R (1987) Das Behçet-Syndrom im Kindesalter. Z Rheumatol 46:174-178
13. Hamza M (1993) Juvenile Behçet's disease. In:Wechsler B, Godeau P (eds) Behçet's disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York, pp 377-380
14. Hamzaoui K, Kahan A, Hamza M, Ayed K (1991) Suppressive T cell function of Epstein-Barr virus induced B cell activation in active Behçet's disease. Clin Exp Rheumatol 9:131-135
15. International Study Group for Behçet's disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
16. Jorizzo JL, Solomon AR, Cavallo T (1985) Behçet's syndrome: immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 109:747-751
17. Katzenellenbogen I, Feuermann EJ (1965) Beitrag zum M. Behçet. (Die Bedeutung der spezifischen Hauthyperreaktivitat und der Bençetinreaktion). Hautarzt 16:13-18
18. Lehner T, Almeida JD, Levinski RJ (1978) Damaged membrane fragments and immune complexes in the blood of patients with Behçet's syndrome. Glin Exp Immunol 34:206-212
19. Plotkin GR (1988) Pathogenesis: miscellaneous factors. In: Plotkin GR, Calabro JJ, O'Duffy JD (eds) Behçet's disease: a contemporary synopsis. Futura, Mount Kisco New York, pp 89-100
20. Rakover Y, Adar H, Tal I, Lang Y, Kedar A (1989) Behçet disease: long-term follow-up of three children and review of the literature. Pediatrics 83:986-992
21. Schneider DT, Jonzzo JL (1987) Behçet's disease and complex aphthosis. Dermatol Clin 5:769-778
22. Shafaie N, Shahram F, Davatchi F, Akbarian M, Ghanbdoost F, Nadji A (1993) Behçet's disease in children. In:Wechsler B, Godeau P (eds) Behçet's disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo, pp 381-383
23. Taylor PV, Chamberlain MA, Scott JS (1993) Autoreactivity in patients with Behçet's disease. Br J Rheumatol 32:908-910
24. Vaiopoulos G, Hatzinikolaou P, Tsiroyanni A, Navropoulos S, Stamatelos G, Terzoglou K, Tzonou A, Economidou I, Kaklamanis Ph (1994) Anti-neutrophil cytoplasmic antibodies in Adamantiadis- Behçet's disease. Br J Rheumatol 33:406-407
25. Wechsler J, Wechsler B, Herreman G, Godeau P, Touraine R, Pinaudeau Y (1981) Maladie de Behçet. Etude en immunofluorescence de l'intradermo-réaction à l'eau distilée. Valeur diagnostique à propos de 50 malades. Med Interne 16:112-117
26. Yamakawa Y, Sugita Y, Takahashi S, Takahashi Y, Nagatani T, Nakajima H (1993) Levels of lnterleukin-6 in patients with Behçet's disease. J Invest Dermalel 101:446
27. Yazici H, Chamberlain MA, Tuzun Y, Yurdakul S, Muftuoglu A (1984) A comparative study of the pathergy reaction among turkish and brrtish patients with Behçet's disease. Ann Rheum Dis 43:74-75
28. Zouboulis ChC (1995) Morbus Adamantiades-Behçet. Klinische und experimentelle Befunde von 53 Patienten aus dem Berliner Raum. Habilitationsschrift, Universitats-Hautklinik und Poliklinik, Klinikum Benjamin Franklin, Freie Universitat Berlin
29. Zouboulis ChC, Buttner P, Djawari D, Kirch W, Keitel W, Garbe C, van Keyserlingk-Ebenus H-J, Orfanos CE (1993) HLA-Muster bei Morbus Adamantiades- Behçet in Deutschland: Assoziation zum Auftreten, der klinischen Symptomatik und dem Krankheitsverlauf bei 39 Patienten. Hautarzt 44:81-84 und 256 (Erratum)
30. Zouboulis ChC, Buttner P, Tebbe B, Orfanos CE (1993) Anticardiolipin antibodies in Adamantiades Behçet's disease. Br J Dermatol 128:281-284